NCT05640986|Unknown
Use of BART Coupled With EEG in the Early Diagnosis of Behavioral Disorders in Parkinson's Disease
COMPARE
Loading search results
COMPARE
Sponsor study identifier
interventional
80
0 countries
N/A
Study Start
January 2, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The Balloon Analogue Risk Task \[BART\] is an experimental task modelizing risky behaviors. In Parkinson disease, the correlation between BART and modifications of cerebral activity in ventral striatum has been shown. BART thus seems to be particularly adapted for modelization of HYPERdopaminergic behavioral disorders \[TYPER\] into Parkinsonian patients. Previously, a version of the BART performed with EEG has been specifically developped by the Centre d'Investigation Clinique of Besançon University Hospital, in collaboration with the Clinical and integrative neurosciences laboratory. Preliminary data suggest that the analysis of evoked potentials including Feedback-related Negativity \[FRN\], P300 wave, and Reward Positivity \[RewP\], could help assessing the motivational and attentional attributes of decision making and the delayed treatment of any reward. The hypothesis of the study that the EEG version of the BART could help predicting the risk to develop TYPER into Parkinsonian patients treated by dopaminergic in routine care.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 29, 2022
Actual (reported)December 7, 2022
Actual (reported)January 2, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Area under curve for dopaminergic agonist treatment
Area Under the Curve / Receiver Operating Characteristic Curve \[AUC-ROC\] of \[FRN\] amplitude measured at baseline for TYPER risk 9 months after introduction or increase of dopaminergic agonist treatment
Month 9
Risky behaviors assessed through BART-EEG among Parkinsonian patients newly treated with dopaminergic agonists
Risky behaviors assessed through BART-EEG among healthy volunteers
Balloon Analogue Risk Task coupled to Electroencephalogram (BART-EEG) at V1 + V2 for Parkinsonian patients
Balloon Analogue Risk Task coupled to Electroencephalogram (BART-EEG) at V1 only for healthy volunteers
Matthieu BEREAU, MD
CHU de Besançon
First Submitted
November 29, 2022
First Posted
December 7, 2022
Study Start
January 2, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 2, 2026
Estimated (date passed)Dual Task and Virtuality Training Innovation to Improve Balance, Posture and Gait in Patients With Parkinson Disease
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 12, 2022
Record last verified: 2022-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: